RxDoctor Payments Data

Donna Espinosa

Women's Health · Torrance, CANPI 1841408622

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.1% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $962 and has fallen 61.4% since, to $371 in 2025. Among women's health clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,666in general payments, 2019–2025

Across 152 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$566
  • Mayne Pharma Commercial LLC$257
  • Ascend Therapeutics US, LLC$227
  • Agile Therapeutics, Inc.$206
  • Organon$168
  • AbbVie$165
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,61498%
  • Education$131%
  • Gifts$381%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,666 in reported general payments places this provider in the 95th percentile of 480 women's health providers in California.

See all women's health providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
ImvexxyEstradiol16$7,572
Estradiol98$5,387
Estradiol (Twice Weekly)Estradiol24$2,572
ProgesteroneProgesterone, Micronized25$913
Clobetasol Propionate15$161

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Therapeuticsmd, Inc.Imvexxy$117$7,57216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 480 women's health providers in California.

Other women's health in Torrance

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →